Preferred Label : Sodium-Glucose transporter 2;

MeSH definition : A sodium-glucose transporter that is expressed in the luminal membrane of the PROXIMAL KIDNEY TUBULES.;

MeSH synonym : sglt2 protein; slc5a2 protein; sodium glucose transporter 2;

Wikipedia link : https://en.wikipedia.org/wiki/Sodium-glucose transporter 2;

Is substance : O;

Details


Main resources

You can consult :

A sodium-glucose transporter that is expressed in the luminal membrane of the PROXIMAL KIDNEY TUBULES.

https://www.revmed.ch/RMS/2017/RMS-N-565/Association-des-analogues-du-GLP-1-et-des-inhibiteurs-du-SGLT2-de-nouvelles-perspectives
2018
false
false
false
Switzerland
French
journal article
administration, oral
hypoglycemic agents
diabetes mellitus, type 2
switzerland
treatment outcome
body weight
cardiovascular diseases
drug therapy, combination
GLP-1 Mimetics
glucagon-like peptide 1
Glucagon-like peptide-1 (GLP-1) analogues
SGLT2 Inhibitor
Sodium-Glucose transporter 2
dulaglutide
Liraglutide
empagliflozin
dapagliflozin
Canagliflozin
blood glucose
arterial pressure
genetic pleiotropy
Sodium-glucose co-transporter 2 (SGLT2) inhibitors
Sodium-Glucose Transporter 2 Inhibitors
dapagliflozin
dapagliflozin
peptides
venoms
immunoglobulin fc fragments
recombinant fusion proteins
glucagon-like peptides
glucagon-like peptides
benzhydryl compounds
glucosides
Exenatide

---
https://www.revmed.ch/RMS/2017/RMS-N-571/Inhibiteur-de-la-DPP-4-ou-des-SGLT2-apres-echec-de-la-metformine-seule-dans-le-diabete-de-type-2
2018
false
false
false
Switzerland
French
journal article
dipeptidyl-peptidase iv inhibitors
Sodium-Glucose transporter 2
SGLT2 Inhibitor
diabetes mellitus, type 2
metformin
treatment outcome
drug therapy, combination
dipeptidyl peptidase 4 (DPP-4) inhibitors
Sodium-glucose co-transporter 2 (SGLT2) inhibitors
Sodium-Glucose Transporter 2 Inhibitors

---
https://www.revmed.ch/RMS/2017/RMS-N-565/Acidocetose-euglycemique-une-complication-des-inhibiteurs-du-SGLT2
2018
false
false
false
Switzerland
French
administration, oral
Sodium-glucose co-transporter 2 (SGLT2) inhibitors
Product containing sodium glucose cotransporter subtype 2 inhibitor (product)
SGLT2 Inhibitor
Sodium-Glucose transporter 2
Canagliflozin
hypoglycemic agents
empagliflozin
dapagliflozin
ketosis
journal article
practice guidelines as topic
precipitating factors
Sodium-Glucose Transporter 2 Inhibitors
dapagliflozin
dapagliflozin
benzhydryl compounds
glucosides

---
https://rmlg.uliege.be/article/2974
2018
false
false
false
false
Belgium
French
journal article
diabetes mellitus, type 2
cardiovascular diseases
hypoglycemic agents
empagliflozin
treatment outcome
empagliflozin
Sodium-Glucose transporter 2
comparative effectiveness research
Liraglutide
liraglutide
Glucagon-Like Peptide-1 Receptor
incretins
case reports
prognosis
cardiovascular diseases
drug therapy, combination
diabetes mellitus, type 2
renal insufficiency, chronic
belgium
insurance, health, reimbursement
Clinical Decision-Making
risk factors
Sodium-Glucose Transporter 2 Inhibitors
benzhydryl compounds
glucosides

---
https://www.revmed.ch/RMS/2017/RMS-N-571/Options-therapeutiques-chez-un-patient-diabetique-de-type-2-mal-controle-par-une-insuline-basale
2017
false
false
false
Switzerland
French
journal article
diabetes mellitus, type 2
administration, oral
insulin
injections, subcutaneous
hypoglycemic agents
dipeptidyl-peptidase iv inhibitors
SGLT2 Inhibitor
Sodium-Glucose transporter 2
drug therapy, combination
Glucagon-Like Peptide-1 Receptor
drug combinations
Sodium-Glucose Transporter 2 Inhibitors

---
SGLT2 inhibitors
https://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/hpiw-ivps_2016-12-fra.php#sglt2
2016
false
false
false
Canada
French
English
drug evaluation
SGLT2 Inhibitor
Sodium-Glucose transporter 2
Canagliflozin
hypoglycemic agents
risk assessment
dapagliflozin
empagliflozin
diabetes mellitus, type 2
fractures, bone
bone demineralization, pathologic
Sodium-Glucose Transporter 2 Inhibitors
dapagliflozin
dapagliflozin
glucosides
benzhydryl compounds

---
https://rmlg.uliege.be/article/2854
2016
false
false
false
Belgium
French
journal article
diabetes mellitus, type 2
dipeptidyl-peptidase iv inhibitors
SGLT2 Inhibitor
dipeptidyl peptidase 4 (DPP-4) inhibitors
Sodium-Glucose transporter 2
comparative effectiveness research
renal insufficiency
other blood glucose lowering drugs, excl. insulins

---
https://smf.swisshealthweb.ch/fr/article/doi/fms.2016.02684/
2016
false
false
false
Switzerland
French
journal article
diabetes mellitus, type 2
dipeptidyl-peptidase iv inhibitors
practice guidelines as topic
glucagon-like peptide 1
GLP-1 Mimetics
GLP-1 Mimetics
dipeptidyl-peptidase iv inhibitors
cardiovascular diseases
obesity
Sodium-Glucose transporter 2
SGLT2 Inhibitor
SGLT2 Inhibitor
insulins
risk factors
weight loss
hypoglycemia
insulins
hypoglycemic agents
Sodium-Glucose Transporter 2 Inhibitors

---
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2016/58404a-fra.php
2016
false
false
false
Canada
French
English
pharmacovigilance note
Sodium-Glucose transporter 2
SGLT2 Inhibitor
Canagliflozin
hypoglycemic agents
dapagliflozin
metformin and dapagliflozin
drug combinations
metformin
empagliflozin
diabetic ketoacidosis
guidelines for drug use
diabetes mellitus, type 2
risk factors
dapagliflozin
canagliflozin
empagliflozin
Sodium-Glucose Transporter 2 Inhibitors
dapagliflozin
dapagliflozin
glucosides
benzhydryl compounds

---
https://smf.swisshealthweb.ch/fr/article/doi/fms.2016.02616/
2016
false
false
false
Switzerland
French
review of literature
administration, oral
SGLT2 Inhibitor
Sodium-Glucose transporter 2
diabetes mellitus, type 2
glycosuria
urinary tract infections
risk factors
candidiasis, vulvovaginal
balanitis
candidal balanitis
hypoglycemic agents
candidiasis, vulvovaginal
balanitis
urinary tract infections
SGLT2 Inhibitor
Sodium-Glucose Transporter 2 Inhibitors

---
Summary Safety Review - SGLT2 Inhibitors (canagliflozin, dapagliflozin, empagliflozin) - Assessing the Potential Risk of Bone-Related Side Effects
https://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/sglt2-3-fra.php
2016
false
false
false
Canada
French
English
Canagliflozin
hypoglycemic agents
dapagliflozin
Sodium-Glucose transporter 2
SGLT2 Inhibitor
risk assessment
drug evaluation
empagliflozin
adult
diabetes mellitus, type 2
fractures, bone
bone demineralization, pathologic
bone and bones
pharmacovigilance note
product surveillance, postmarketing
canada
dapagliflozin
canagliflozin
empagliflozin
Sodium-Glucose Transporter 2 Inhibitors
dapagliflozin
dapagliflozin
benzhydryl compounds
glucosides

---
http://www.revmed.ch/RMS/2015/RMS-N-477/Analogues-du-GLP-1-versus-inhibiteurs-du-SGLT-2-pour-les-diabetiques-de-type-2-obeses
2015
false
false
false
Switzerland
French
diabetes mellitus, type 2
obesity
comparative effectiveness research
treatment outcome
incretins
hypoglycemic agents
Liraglutide
glucagon-like peptide 1
Canagliflozin
Sodium-Glucose transporter 2
SGLT2 Inhibitor
dapagliflozin
empagliflozin
1,5-anhydro-1-(5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl)-1-thioglucitol
other blood glucose lowering drugs, excl. insulins
GLP-1 Mimetics
journal article
Sodium-Glucose Transporter 2 Inhibitors
dapagliflozin
dapagliflozin
glucosides
benzhydryl compounds
peptides
venoms
sorbitol
sorbitol
Exenatide

---
http://www.revmed.ch/RMS/2015/RMS-N-463/Les-inhibiteurs-du-cotransporteur-SGLT2-comme-nouveau-traitement-du-diabete-aspects-renaux
2015
false
false
false
Switzerland
French
journal article
kidney, nos
new
Sodium-Glucose transporter 2
therapeutics
diabetes mellitus
with pattern

---
https://minerva-ebp.be/fr/article/1088
2015
false
false
false
minerva-ebm.be
Belgium
French
critical appraisal or critical reading
diabetes mellitus, type 2
Sodium-Glucose transporter 2
treatment outcome
hypoglycemic agents
Sodium-Glucose Transporter 2 Inhibitors
Sodium-Glucose Transporter 2 Inhibitors

---
http://www.amub-ulb.be/revue-medicale-bruxelles/article/les-nouveaux-anti-diabetiques-oraux-1032
2014
false
false
false
false
Belgium
French
journal article
comparative study
diabetes mellitus, type 2
incretins
hypoglycemic agents
administration, oral
incretins
gastric inhibitory polypeptide
glucagon-like peptide 1
dipeptidyl-peptidase iv inhibitors
dipeptidyl peptidase 4 (DPP-4) inhibitors
other blood glucose lowering drugs, excl. insulins
incretins
hypoglycemic agents
hypoglycemic agents
SLC5A2 protein, human
risk factors
drug therapy, combination
treatment outcome
Glucagon-Like Peptide-1 Receptor
Sodium-Glucose Transporter 2 Inhibitors
Sodium-Glucose transporter 2

---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=69076
2006
France
French
rare diseases
Sodium-Glucose transporter 2
glycosuria, renal
scientific and technical information

---
Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.